Lv11
30 积分 2024-05-09 加入
First-line treatments for advanced or recurrent endometrial cancer: systematic literature review of clinical evidence
4小时前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
5个月前
已完结
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
6个月前
已完结
A cross-population atlas of genetic associations for 220 human phenotypes
6个月前
已完结
皖公网安备34019202002308
